Global Dry Eye Syndrome Market Growth 2022-2028
As the global economy mends, the 2021 growth of Dry Eye Syndrome will have significant change from previous year. According to our latest study, the global Dry Eye Syndrome market size is USD million in 2022 from USD 5267.9 million in 2021, with a change of % between 2021 and 2022. The global Dry Eye Syndrome market size will reach USD 7250 million in 2028, growing at a CAGR of 4.7% over the analysis period.
The United States Dry Eye Syndrome market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dry Eye Syndrome market, reaching US$ million by the year 2028. As for the Europe Dry Eye Syndrome landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dry Eye Syndrome players cover Allergan, Alcon, Novartis, and Santen Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Syndrome market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Artificial Tears
Anti-inflammatory Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Eye Syndrome Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dry Eye Syndrome by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dry Eye Syndrome by Country/Region, 2017, 2022 & 2028
2.2 Dry Eye Syndrome Segment by Type
2.2.1 Artificial Tears
2.2.2 Anti-inflammatory Drugs
2.2.3 Others
2.3 Dry Eye Syndrome Sales by Type
2.3.1 Global Dry Eye Syndrome Sales Market Share by Type (2017-2022)
2.3.2 Global Dry Eye Syndrome Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dry Eye Syndrome Sale Price by Type (2017-2022)
2.4 Dry Eye Syndrome Segment by Distribution Channel
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Dry Eye Syndrome Sales by Distribution Channel
2.5.1 Global Dry Eye Syndrome Sale Market Share by Distribution Channel (2017-2022)
2.5.2 Global Dry Eye Syndrome Revenue and Market Share by Distribution Channel (2017-2022)
2.5.3 Global Dry Eye Syndrome Sale Price by Distribution Channel (2017-2022)
3 Global Dry Eye Syndrome by Company
3.1 Global Dry Eye Syndrome Breakdown Data by Company
3.1.1 Global Dry Eye Syndrome Annual Sales by Company (2020-2022)
3.1.2 Global Dry Eye Syndrome Sales Market Share by Company (2020-2022)
3.2 Global Dry Eye Syndrome Annual Revenue by Company (2020-2022)
3.2.1 Global Dry Eye Syndrome Revenue by Company (2020-2022)
3.2.2 Global Dry Eye Syndrome Revenue Market Share by Company (2020-2022)
3.3 Global Dry Eye Syndrome Sale Price by Company
3.4 Key Manufacturers Dry Eye Syndrome Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Eye Syndrome Product Location Distribution
3.4.2 Players Dry Eye Syndrome Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dry Eye Syndrome by Geographic Region
4.1 World Historic Dry Eye Syndrome Market Size by Geographic Region (2017-2022)
4.1.1 Global Dry Eye Syndrome Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dry Eye Syndrome Annual Revenue by Geographic Region
4.2 World Historic Dry Eye Syndrome Market Size by Country/Region (2017-2022)
4.2.1 Global Dry Eye Syndrome Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dry Eye Syndrome Annual Revenue by Country/Region
4.3 Americas Dry Eye Syndrome Sales Growth
4.4 APAC Dry Eye Syndrome Sales Growth
4.5 Europe Dry Eye Syndrome Sales Growth
4.6 Middle East & Africa Dry Eye Syndrome Sales Growth
5 Americas
5.1 Americas Dry Eye Syndrome Sales by Country
5.1.1 Americas Dry Eye Syndrome Sales by Country (2017-2022)
5.1.2 Americas Dry Eye Syndrome Revenue by Country (2017-2022)
5.2 Americas Dry Eye Syndrome Sales by Type
5.3 Americas Dry Eye Syndrome Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Eye Syndrome Sales by Region
6.1.1 APAC Dry Eye Syndrome Sales by Region (2017-2022)
6.1.2 APAC Dry Eye Syndrome Revenue by Region (2017-2022)
6.2 APAC Dry Eye Syndrome Sales by Type
6.3 APAC Dry Eye Syndrome Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dry Eye Syndrome by Country
7.1.1 Europe Dry Eye Syndrome Sales by Country (2017-2022)
7.1.2 Europe Dry Eye Syndrome Revenue by Country (2017-2022)
7.2 Europe Dry Eye Syndrome Sales by Type
7.3 Europe Dry Eye Syndrome Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dry Eye Syndrome by Country
8.1.1 Middle East & Africa Dry Eye Syndrome Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dry Eye Syndrome Revenue by Country (2017-2022)
8.2 Middle East & Africa Dry Eye Syndrome Sales by Type
8.3 Middle East & Africa Dry Eye Syndrome Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Eye Syndrome
10.3 Manufacturing Process Analysis of Dry Eye Syndrome
10.4 Industry Chain Structure of Dry Eye Syndrome
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dry Eye Syndrome Distributors
11.3 Dry Eye Syndrome Customer
12 World Forecast Review for Dry Eye Syndrome by Geographic Region
12.1 Global Dry Eye Syndrome Market Size Forecast by Region
12.1.1 Global Dry Eye Syndrome Forecast by Region (2023-2028)
12.1.2 Global Dry Eye Syndrome Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dry Eye Syndrome Forecast by Type
12.7 Global Dry Eye Syndrome Forecast by Distribution Channel
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Dry Eye Syndrome Product Offered
13.1.3 Allergan Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Dry Eye Syndrome Product Offered
13.2.3 Alcon Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Dry Eye Syndrome Product Offered
13.3.3 Novartis Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Santen Pharma
13.4.1 Santen Pharma Company Information
13.4.2 Santen Pharma Dry Eye Syndrome Product Offered
13.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Santen Pharma Main Business Overview
13.4.5 Santen Pharma Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Dry Eye Syndrome Product Offered
13.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Bausch & Lomb
13.6.1 Bausch & Lomb Company Information
13.6.2 Bausch & Lomb Dry Eye Syndrome Product Offered
13.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bausch & Lomb Main Business Overview
13.6.5 Bausch & Lomb Latest Developments
13.7 Thea pharmaceuticals
13.7.1 Thea pharmaceuticals Company Information
13.7.2 Thea pharmaceuticals Dry Eye Syndrome Product Offered
13.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Thea pharmaceuticals Main Business Overview
13.7.5 Thea pharmaceuticals Latest Developments
13.8 URSAPHARM
13.8.1 URSAPHARM Company Information
13.8.2 URSAPHARM Dry Eye Syndrome Product Offered
13.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 URSAPHARM Main Business Overview
13.8.5 URSAPHARM Latest Developments
13.9 SIMILASAN
13.9.1 SIMILASAN Company Information
13.9.2 SIMILASAN Dry Eye Syndrome Product Offered
13.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SIMILASAN Main Business Overview
13.9.5 SIMILASAN Latest Developments
13.10 Akorn
13.10.1 Akorn Company Information
13.10.2 Akorn Dry Eye Syndrome Product Offered
13.10.3 Akorn Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Akorn Main Business Overview
13.10.5 Akorn Latest Developments
13.11 United Laboratories
13.11.1 United Laboratories Company Information
13.11.2 United Laboratories Dry Eye Syndrome Product Offered
13.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 United Laboratories Main Business Overview
13.11.5 United Laboratories Latest Developments
13.12 Sun Pharmaceutical
13.12.1 Sun Pharmaceutical Company Information
13.12.2 Sun Pharmaceutical Dry Eye Syndrome Product Offered
13.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sun Pharmaceutical Main Business Overview
13.12.5 Sun Pharmaceutical Latest Developments
13.13 Jianfeng Group
13.13.1 Jianfeng Group Company Information
13.13.2 Jianfeng Group Dry Eye Syndrome Product Offered
13.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jianfeng Group Main Business Overview
13.13.5 Jianfeng Group Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Dry Eye Syndrome Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dry Eye Syndrome Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Artificial Tears
Table 4. Major Players of Anti-inflammatory Drugs
Table 5. Major Players of Others
Table 6. Global Dry Eye Syndrome Sales by Type (2017-2022) & (M Units)
Table 7. Global Dry Eye Syndrome Sales Market Share by Type (2017-2022)
Table 8. Global Dry Eye Syndrome Revenue by Type (2017-2022) & ($ million)
Table 9. Global Dry Eye Syndrome Revenue Market Share by Type (2017-2022)
Table 10. Global Dry Eye Syndrome Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Dry Eye Syndrome Sales by Distribution Channel (2017-2022) & (M Units)
Table 12. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Table 13. Global Dry Eye Syndrome Revenue by Distribution Channel (2017-2022)
Table 14. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2017-2022)
Table 15. Global Dry Eye Syndrome Sale Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 16. Global Dry Eye Syndrome Sales by Company (2020-2022) & (M Units)
Table 17. Global Dry Eye Syndrome Sales Market Share by Company (2020-2022)
Table 18. Global Dry Eye Syndrome Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Dry Eye Syndrome Revenue Market Share by Company (2020-2022)
Table 20. Global Dry Eye Syndrome Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Dry Eye Syndrome Producing Area Distribution and Sales Area
Table 22. Players Dry Eye Syndrome Products Offered
Table 23. Dry Eye Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Dry Eye Syndrome Sales by Geographic Region (2017-2022) & (M Units)
Table 27. Global Dry Eye Syndrome Sales Market Share Geographic Region (2017-2022)
Table 28. Global Dry Eye Syndrome Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Dry Eye Syndrome Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Dry Eye Syndrome Sales by Country/Region (2017-2022) & (M Units)
Table 31. Global Dry Eye Syndrome Sales Market Share by Country/Region (2017-2022)
Table 32. Global Dry Eye Syndrome Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Dry Eye Syndrome Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Dry Eye Syndrome Sales by Country (2017-2022) & (M Units)
Table 35. Americas Dry Eye Syndrome Sales Market Share by Country (2017-2022)
Table 36. Americas Dry Eye Syndrome Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Dry Eye Syndrome Revenue Market Share by Country (2017-2022)
Table 38. Americas Dry Eye Syndrome Sales by Type (2017-2022) & (M Units)
Table 39. Americas Dry Eye Syndrome Sales Market Share by Type (2017-2022)
Table 40. Americas Dry Eye Syndrome Sales by Distribution Channel (2017-2022) & (M Units)
Table 41. Americas Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Table 42. APAC Dry Eye Syndrome Sales by Region (2017-2022) & (M Units)
Table 43. APAC Dry Eye Syndrome Sales Market Share by Region (2017-2022)
Table 44. APAC Dry Eye Syndrome Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Dry Eye Syndrome Revenue Market Share by Region (2017-2022)
Table 46. APAC Dry Eye Syndrome Sales by Type (2017-2022) & (M Units)
Table 47. APAC Dry Eye Syndrome Sales Market Share by Type (2017-2022)
Table 48. APAC Dry Eye Syndrome Sales by Distribution Channel (2017-2022) & (M Units)
Table 49. APAC Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Table 50. Europe Dry Eye Syndrome Sales by Country (2017-2022) & (M Units)
Table 51. Europe Dry Eye Syndrome Sales Market Share by Country (2017-2022)
Table 52. Europe Dry Eye Syndrome Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Dry Eye Syndrome Revenue Market Share by Country (2017-2022)
Table 54. Europe Dry Eye Syndrome Sales by Type (2017-2022) & (M Units)
Table 55. Europe Dry Eye Syndrome Sales Market Share by Type (2017-2022)
Table 56. Europe Dry Eye Syndrome Sales by Distribution Channel (2017-2022) & (M Units)
Table 57. Europe Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Table 58. Middle East & Africa Dry Eye Syndrome Sales by Country (2017-2022) & (M Units)
Table 59. Middle East & Africa Dry Eye Syndrome Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Dry Eye Syndrome Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Dry Eye Syndrome Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Dry Eye Syndrome Sales by Type (2017-2022) & (M Units)
Table 63. Middle East & Africa Dry Eye Syndrome Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Dry Eye Syndrome Sales by Distribution Channel (2017-2022) & (M Units)
Table 65. Middle East & Africa Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Dry Eye Syndrome
Table 67. Key Market Challenges & Risks of Dry Eye Syndrome
Table 68. Key Industry Trends of Dry Eye Syndrome
Table 69. Dry Eye Syndrome Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Dry Eye Syndrome Distributors List
Table 72. Dry Eye Syndrome Customer List
Table 73. Global Dry Eye Syndrome Sales Forecast by Region (2023-2028) & (M Units)
Table 74. Global Dry Eye Syndrome Sales Market Forecast by Region
Table 75. Global Dry Eye Syndrome Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Dry Eye Syndrome Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Dry Eye Syndrome Sales Forecast by Country (2023-2028) & (M Units)
Table 78. Americas Dry Eye Syndrome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Dry Eye Syndrome Sales Forecast by Region (2023-2028) & (M Units)
Table 80. APAC Dry Eye Syndrome Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Dry Eye Syndrome Sales Forecast by Country (2023-2028) & (M Units)
Table 82. Europe Dry Eye Syndrome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Dry Eye Syndrome Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Middle East & Africa Dry Eye Syndrome Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Dry Eye Syndrome Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Dry Eye Syndrome Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Dry Eye Syndrome Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Dry Eye Syndrome Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Dry Eye Syndrome Sales Forecast by Distribution Channel (2023-2028) & (M Units)
Table 90. Global Dry Eye Syndrome Sales Market Share Forecast by Distribution Channel (2023-2028)
Table 91. Global Dry Eye Syndrome Revenue Forecast by Distribution Channel (2023-2028) & ($ Millions)
Table 92. Global Dry Eye Syndrome Revenue Market Share Forecast by Distribution Channel (2023-2028)
Table 93. Allergan Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergan Dry Eye Syndrome Product Offered
Table 95. Allergan Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Allergan Main Business
Table 97. Allergan Latest Developments
Table 98. Alcon Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 99. Alcon Dry Eye Syndrome Product Offered
Table 100. Alcon Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Alcon Main Business
Table 102. Alcon Latest Developments
Table 103. Novartis Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Dry Eye Syndrome Product Offered
Table 105. Novartis Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Santen Pharma Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 109. Santen Pharma Dry Eye Syndrome Product Offered
Table 110. Santen Pharma Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Santen Pharma Main Business
Table 112. Santen Pharma Latest Developments
Table 113. Johnson & Johnson Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Dry Eye Syndrome Product Offered
Table 115. Johnson & Johnson Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. Bausch & Lomb Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 119. Bausch & Lomb Dry Eye Syndrome Product Offered
Table 120. Bausch & Lomb Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Bausch & Lomb Main Business
Table 122. Bausch & Lomb Latest Developments
Table 123. Thea pharmaceuticals Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 124. Thea pharmaceuticals Dry Eye Syndrome Product Offered
Table 125. Thea pharmaceuticals Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Thea pharmaceuticals Main Business
Table 127. Thea pharmaceuticals Latest Developments
Table 128. URSAPHARM Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 129. URSAPHARM Dry Eye Syndrome Product Offered
Table 130. URSAPHARM Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. URSAPHARM Main Business
Table 132. URSAPHARM Latest Developments
Table 133. SIMILASAN Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 134. SIMILASAN Dry Eye Syndrome Product Offered
Table 135. SIMILASAN Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. SIMILASAN Main Business
Table 137. SIMILASAN Latest Developments
Table 138. Akorn Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 139. Akorn Dry Eye Syndrome Product Offered
Table 140. Akorn Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Akorn Main Business
Table 142. Akorn Latest Developments
Table 143. United Laboratories Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 144. United Laboratories Dry Eye Syndrome Product Offered
Table 145. United Laboratories Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. United Laboratories Main Business
Table 147. United Laboratories Latest Developments
Table 148. Sun Pharmaceutical Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 149. Sun Pharmaceutical Dry Eye Syndrome Product Offered
Table 150. Sun Pharmaceutical Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Sun Pharmaceutical Main Business
Table 152. Sun Pharmaceutical Latest Developments
Table 153. Jianfeng Group Basic Information, Dry Eye Syndrome Manufacturing Base, Sales Area and Its Competitors
Table 154. Jianfeng Group Dry Eye Syndrome Product Offered
Table 155. Jianfeng Group Dry Eye Syndrome Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Jianfeng Group Main Business
Table 157. Jianfeng Group Latest Developments
List of Figures
Figure 1. Picture of Dry Eye Syndrome
Figure 2. Dry Eye Syndrome Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Eye Syndrome Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Dry Eye Syndrome Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dry Eye Syndrome Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Artificial Tears
Figure 10. Product Picture of Anti-inflammatory Drugs
Figure 11. Product Picture of Others
Figure 12. Global Dry Eye Syndrome Sales Market Share by Type in 2021
Figure 13. Global Dry Eye Syndrome Revenue Market Share by Type (2017-2022)
Figure 14. Dry Eye Syndrome Consumed in Hospital
Figure 15. Global Dry Eye Syndrome Market: Hospital (2017-2022) & (M Units)
Figure 16. Dry Eye Syndrome Consumed in Retail Pharmacy
Figure 17. Global Dry Eye Syndrome Market: Retail Pharmacy (2017-2022) & (M Units)
Figure 18. Dry Eye Syndrome Consumed in Others
Figure 19. Global Dry Eye Syndrome Market: Others (2017-2022) & (M Units)
Figure 20. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)
Figure 21. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel in 2021
Figure 22. Dry Eye Syndrome Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Dry Eye Syndrome Revenue Market Share by Company in 2021
Figure 24. Global Dry Eye Syndrome Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Dry Eye Syndrome Revenue Market Share by Geographic Region in 2021
Figure 26. Global Dry Eye Syndrome Sales Market Share by Region (2017-2022)
Figure 27. Global Dry Eye Syndrome Revenue Market Share by Country/Region in 2021
Figure 28. Americas Dry Eye Syndrome Sales 2017-2022 (M Units)
Figure 29. Americas Dry Eye Syndrome Revenue 2017-2022 ($ Millions)
Figure 30. APAC Dry Eye Syndrome Sales 2017-2022 (M Units)
Figure 31. APAC Dry Eye Syndrome Revenue 2017-2022 ($ Millions)
Figure 32. Europe Dry Eye Syndrome Sales 2017-2022 (M Units)
Figure 33. Europe Dry Eye Syndrome Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Dry Eye Syndrome Sales 2017-2022 (M Units)
Figure 35. Middle East & Africa Dry Eye Syndrome Revenue 2017-2022 ($ Millions)
Figure 36. Americas Dry Eye Syndrome Sales Market Share by Country in 2021
Figure 37. Americas Dry Eye Syndrome Revenue Market Share by Country in 2021
Figure 38. United States Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Dry Eye Syndrome Sales Market Share by Region in 2021
Figure 43. APAC Dry Eye Syndrome Revenue Market Share by Regions in 2021
Figure 44. China Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Dry Eye Syndrome Sales Market Share by Country in 2021
Figure 51. Europe Dry Eye Syndrome Revenue Market Share by Country in 2021
Figure 52. Germany Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Dry Eye Syndrome Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Dry Eye Syndrome Revenue Market Share by Country in 2021
Figure 59. Egypt Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Dry Eye Syndrome Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Dry Eye Syndrome in 2021
Figure 65. Manufacturing Process Analysis of Dry Eye Syndrome
Figure 66. Industry Chain Structure of Dry Eye Syndrome
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
